Meet the Research Team
 |
X. J. Meng, MD, MSc, PhD
Professor of Molecular Virology, Department of Biomedical Sciences and Pathobiology, Virginia Polytechnic Institute and State University.
- Lead scientist in the research and development effort of Suvaxyn® PCV2 One Dose
- Conceived the original idea in 1999 for the development of the chimeric formula
|
 |
Martijn Fenaux, PhD
Research Scientist, Gilead Sciences
- "Constructed" the chimeric virus used in Suvaxyn PCV2 One Dose
- Developed the assays used to determine PCV2 viral loads of tissue samples
- Led research studies for in vitro characterization, in vivo pathogenicity, immunogenicity and challenge assessments of the chimeric virus used in Suvaxyn PCV2 One Dose
|
 |
Pat G. Halbur, DVM, MSc, PhD
Professor and Chairperson, Department of Veterinary Diagnostic and Production Animal Medicine;
Executive Director, Veterinary Diagnostic Laboratory, Iowa State University
- Assessed immunogenicity of the chimeric circovirus
- Conducted in vitro characterization, in vivo pathogenicity, immunogenicity and challenge studies of the chimeric virus used in Suvaxyn PCV2 One Dose
- Developed assays used to determine PCV2 viral loads in tissue samples
|
 |
Tanja Opriessnig, Dr. Med. Vet., PhD
Assistant Professor, Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University
- Assessed immunogenicity of the chimeric circovirus
- Evaluated vaccine prototypes
|
 |
Steve Chu, MSc, PhD, DVM
Senior Vice President, Global Research and Development,
Fort Dodge Animal Health
- Oversees the Fort Dodge Animal Health research team responsible for several innovative vaccines
- Has been awarded several key vaccine patents
|
 |
Mike Gill, BSc, MS, PhD
Senior Director, Viral and Small Animal Research and Development,
Fort Dodge Animal Health
- Designed the studies that allowed Fort Dodge Animal Health to gain licensure for Suvaxyn PCV2 One Dose
- Has helped develop several important swine, canine and feline biological products
|
 |
Stephen Q. Wu, MSc, PhD
Senior Manager, Biotechnology Research and Vaccine Development,
Fort Dodge Animal Health
- Took the chimeric prototype vaccine and formulated it into an efficacious, one-dose, adjuvanted, killed virus vaccine for commercial use
|
|
|
